Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Allison E. Axtell"'
Autor:
Lue-Yen Tucker, Romain Neugebauer, Tina Raine-Bennett, Scott E. Lentz, Peter M. Schultze, Julia Embry-Schubert, Ted E. Palen, Eve Zaritsky, Alvina Sundang, Amy L. Compton-Phillips, David W. Kronbach, Ramey D. Littell, Allison E. Axtell, Kimberly J. Bischoff
Publikováno v:
Obstetrics and gynecology. 127(1)
To estimate the incidence of occult uterine sarcoma and leiomyosarcoma in hysterectomies for leiomyomas and the risk associated with their morcellation.We conducted a population-based cohort study. All uterine sarcomas from 2006-2013 in an integrated
Autor:
Antonio Santillan, Eric L. Eisenhauer, Dennis S. Chi, Giacomo Aletti, Christine H. Holschneider, Robert E. Bristow, William A. Cliby, Allison E. Axtell, Giovanni Aletti
Publikováno v:
Gynecologic Oncology. 120:23-28
Objective Define subgroups of patients at highest risk for major morbidity and mortality after a traditional approach of maximal surgical efforts followed by chemotherapy for advanced ovarian cancer (AOC). Methods Preoperative health, intra-operative
Autor:
Joseph L. Kelley, Paola A. Gehrig, Laura J. Havrilesky, Amanda N. Fader, Allison E. Axtell, Kathleen N. Moore, Angeles Alvarez Secord, Kristine M. Zanotti, Peter G. Rose, Erin Tuller, Heidi Frasure, Warner K. Huh, David Starks, David M. O'Malley
Publikováno v:
Gynecologic Oncology. 115:244-248
Objectives Stage I–II uterine papillary serous carcinoma (UPSC) patients have a significant risk for extrapelvic recurrence. However, clinicopathologic risk factors for recurrence are not well understood. This study was undertaken to define the pro
Autor:
Kristine M. Zanotti, Allison E. Axtell, Amanda N. Fader, Paola A. Gehrig, Warner K. Huh, David M. O'Malley, Laura J. Havrilesky, Erin Tuller, Richard D. Drake, Heidi E. Gibbons
Publikováno v:
Cancer. 115:2119-2127
BACKGROUND: A study was undertaken to determine recurrence patterns and survival outcomes of stage I uterine papillary serous carcinoma (UPSC) patients. METHODS: A retrospective, multi-institutional study of stage I UPSC patients diagnosed from 1993
New edition fully includes Grades and Levels of evidence, providing a better idea of what the sum total of existing evidence suggests regarding key topics Grades and levels of evidence consistently highlighted throughout Greater number of tables and
Autor:
Amanda Nickles, Fader, Richard D, Drake, David M, O'Malley, Heidi E, Gibbons, Warner K, Huh, Laura J, Havrilesky, Paola A, Gehrig, Erin, Tuller, Allison E, Axtell, Kristine M, Zanotti
Publikováno v:
Cancer. 115(10)
A study was undertaken to determine recurrence patterns and survival outcomes of stage I uterine papillary serous carcinoma (UPSC) patients.A retrospective, multi-institutional study of stage I UPSC patients diagnosed from 1993 to 2006 was performed.
Autor:
Christa Nagel, Warner K. Huh, Christine Walsh, Justin Bottsford-Miller, Erin Tuller, David M. O'Malley, Amanda N. Fader, Laura J. Havrilesky, Richard D. Drake, Kathleen N. Moore, Peter G. Rose, Joseph L. Kelley, Paola A. Gehrig, Heidi E. Gibbons, Kristine M. Zanotti, Allison E. Axtell, Angeles Alvarez Secord
Publikováno v:
Gynecologic oncology. 112(3)
Objectives To determine recurrence patterns and survival outcomes of stage II uterine papillary serous carcinoma (UPSC) patients treated by various modalities with an emphasis on carboplatin/paclitaxel-based chemotherapy (CT)+/−radiotherapy (RT). M
Autor:
Melissa A. Gerardi, Robert E. Bristow, Ritu Salani, Christine H. Holschneider, Allison E. Axtell
Publikováno v:
Gynecologic oncology. 108(2)
Objective To evaluate the predictive value of conventional criteria for identifying surgically unresectable disease among patients with ovarian cancer undergoing initial operative intervention at tertiary referral centers employing a so-called aggres
Autor:
Michael A. Gold, Charles A. Leath, Ilana Cass, Lisa N. Abaid, Katherine M. Moxley, Derek Blankenship, Rodney P. Rocconi, Peter G. Rose, Teresa Rutledge, Kathleen N. Moore, Amanda N. Fader, Allison E. Axtell
Publikováno v:
Gynecologic oncology. 107(3)
Primary carcinoma of the fallopian tube (PCFT) accounts for perhaps 1% of genital tract cancers. The investigators undertook a matched, case-control comparison of 96 women with a diagnosis of PCFT and 189 control women having ovarian carcinoma (OC).